FDA 510(k) Cleared

MyoVista Insights

AI-powered ECG analysis software that detects cardiac abnormalities with clinical-grade accuracy, enabling earlier intervention and better patient outcomes.

Software Interface

Powered by Advanced AI

Our machine learning algorithms analyze ECG signals at a depth impossible for the human eye, detecting subtle patterns that indicate early-stage cardiac dysfunction.

Deep Learning Analysis

Advanced neural networks trained on millions of ECGs to detect subtle patterns invisible to traditional analysis.

Real-time Results

Get comprehensive analysis results in under 60 seconds from the time of ECG acquisition.

EHR Integration

Seamless integration with Epic, Cerner, and other major EHR systems for streamlined workflows.

Detailed Reports

Comprehensive clinical reports with risk scores, findings, and actionable recommendations.

FDA Cleared

Regulatory clearance ensures the highest standards of safety and efficacy for clinical use.

Expert Support

Dedicated clinical support team to assist with implementation and ongoing optimization.

Conditions Detected

MyoVista Insights can detect a wide range of cardiac conditions with clinically validated accuracy.

87%

Diastolic Dysfunction

Early detection of HFpEF

91%

Low Ejection Fraction

LVEF < 40% screening

94%

Atrial Fibrillation

AFib and flutter detection

82%

Coronary Artery Disease

Significant CAD indicators

85%

Hypertrophic CM

HCM pattern recognition

96%

QT Prolongation

Long QT syndrome

88%

Left Ventricular Hypertrophy

LVH detection

79%

Pulmonary Hypertension

PH indicators

Schedule Your Demo Today

See how HeartSciences can transform cardiovascular care at your institution. Our team will walk you through the platform and answer all your questions.

Personalized platform demonstration
Clinical evidence review
Custom pricing and implementation plan
No obligation consultation

Request a Demo

By submitting, you agree to our Privacy Policy.